APA citáció

Lontai Livia, Gönczi Lóránt, Balogh Fruzsina, Komlodi Nóra, Resál Tamás, Farkas Klaudia, . . . Lakatos Péter László. (2022). Non-medical switch from the originator to biosimilar and between biosimilars of adalimumab in inflammatory bowel disease – a prospective, multicentre study.

Chicago Style (17th ed.) Citation

Lontai Livia, et al. Non-medical Switch from the Originator to Biosimilar and Between Biosimilars of Adalimumab in Inflammatory Bowel Disease – a Prospective, Multicentre Study. 2022.

MLA idézés

Lontai Livia, et al. Non-medical Switch from the Originator to Biosimilar and Between Biosimilars of Adalimumab in Inflammatory Bowel Disease – a Prospective, Multicentre Study. 2022.